These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25872475)

  • 1. Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.
    Borlak J; Singh P; Gazzana G
    BMC Genomics; 2015 Feb; 16(1):124. PubMed ID: 25872475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF is highly expressed in hepatocellular carcinoma (HCC) and promotes motility of HCC cells via fibronectin.
    Liu Z; Chen D; Ning F; Du J; Wang H
    J Cell Biochem; 2018 May; 119(5):4170-4183. PubMed ID: 29315755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours.
    Borlak J; Meier T; Halter R; Spanel R; Spanel-Borowski K
    Oncogene; 2005 Mar; 24(11):1809-19. PubMed ID: 15674348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
    Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
    Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].
    Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM
    Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
    Huang P; Xu X; Wang L; Zhu B; Wang X; Xia J
    J Cell Mol Med; 2014 Feb; 18(2):218-30. PubMed ID: 24268047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
    Wang S; Huang X; Li Y; Lao H; Zhang Y; Dong H; Xu W; Li JL; Li M
    Hepatology; 2011 Jun; 53(6):1932-42. PubMed ID: 21391225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
    Rovida E; Di Maira G; Tusa I; Cannito S; Paternostro C; Navari N; Vivoli E; Deng X; Gray NS; Esparís-Ogando A; David E; Pandiella A; Dello Sbarba P; Parola M; Marra F
    Gut; 2015 Sep; 64(9):1454-65. PubMed ID: 25183205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal role of mTOR signaling in hepatocellular carcinoma.
    Villanueva A; Chiang DY; Newell P; Peix J; Thung S; Alsinet C; Tovar V; Roayaie S; Minguez B; Sole M; Battiston C; Van Laarhoven S; Fiel MI; Di Feo A; Hoshida Y; Yea S; Toffanin S; Ramos A; Martignetti JA; Mazzaferro V; Bruix J; Waxman S; Schwartz M; Meyerson M; Friedman SL; Llovet JM
    Gastroenterology; 2008 Dec; 135(6):1972-83, 1983.e1-11. PubMed ID: 18929564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
    Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
    Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteome mapping of EGF transgenic mice reveal mechanistic biomarkers of lung cancer precursor lesions with clinical significance for human adenocarcinomas.
    Borlak J; Länger F; Chatterji B
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3122-3144. PubMed ID: 29960043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
    Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
    Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
    Niehof M; Borlak J
    Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.